MARKET

LWAY

LWAY

Lifeway Foods
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.40
+0.57
+8.35%
Closed 16:00 11/27 EST
OPEN
6.99
PREV CLOSE
6.83
HIGH
7.96
LOW
6.85
VOLUME
115.71K
TURNOVER
--
52 WEEK HIGH
8.89
52 WEEK LOW
1.430
MARKET CAP
115.47M
P/E (TTM)
30.90
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Do Hedge Funds Love Lifeway Foods, Inc. (LWAY)?
In this article we are going to use hedge fund sentiment as a tool and determine whether Lifeway Foods, Inc. (NASDAQ:LWAY) is a good investment right now. We like to analyze hedge fund sentiment before conducting days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy League graduates, […]
Insider Monkey · 11h ago
Lifeway Foods Applauds Recent Scientific Review Highlighting Kefir as a Potential Protective Dietary Supplementation Against Viral Infection
Review suggests utilization of kefir as an inhibitor of expression of proinflammatory cytokines in COVID-19 could be viable policyMORTON GROVE, Ill., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome commends the recent review published in Biomedicine & Pharmacotherapy where it posits the probiotics in kefir have immune supporting properties that may be of benefit against infections, including COVID-19. With the world awaiting a vaccine to combat the novel coronavirus, consumer demand for products and methods to boost the immune system and suppress viral infections is on the rise. The review discusses the following about kefir, the fermented milk made from kefir grains: * Kefir and kefir derivatives can suppress viral activity by modulating immune-system responses and/or causing disruption of viral adhesion [26,27]. * The antiviral mechanisms of kefir involve enhancement of macrophage production and boosting the activity of proinflammatory cytokines [27]. * Kefir dietaries have anti-inflammatory activity by inhibiting the activity of proinflammatory cytokines such as IL-1β, TNF-α and IL-6, meaning the nutrients and various biomolecules produced [27]. “At Lifeway Foods, we are on a mission to keep our communities healthy, and a big part of that mission is educating consumers that good health and immunity starts within the gut,” states Julie Smolyansky, CEO of Lifeway Foods, Inc. “With viral infections like COVID-19 at the forefront of our minds, it’s important that studies like this continue to educate and demonstrate to people everywhere how probiotic products such as kefir may help mitigate the viral risks we all face. This review builds upon the foundation of Nobel Prize winner Élie Metchnikoff’s research on immunology. Metchnikoff is revered for first discovering the connection between immunity and probiotic fermented milk products, such as kefir, over 100 years ago. Today, we honor his legacy by celebrating the ongoing research and spreading the word about the benefits of probiotics and kefir.”As the leading U.S. supplier of kefir, Lifeway Kefir is made with 12 active cultures and packed with protein, calcium and vitamin D. Each product is loaded with probiotics, which research suggests may help to support the microbiome and protect against infections. Additionally, probiotic products such as Lifeway Kefir may help support the body’s response to decrease inflammation.To learn more about Lifeway and its products, visit lifewayfoods.com. To view the full review published in Biomedicine & Pharmacotherapy Volume 133, visit Sciencedirect.com.About Lifeway FoodsLifeway Foods, Inc., which has been recognized as one of Forbes’ Best Small Companies, is America’s leading supplier of the probiotic, fermented beverage known as kefir. In addition to its line of drinkable kefir, the company also produces cupped kefir and cheese, frozen kefir, specialty cheeses, probiotic supplements and a ProBugs line for kids. Lifeway’s tart and tangy fermented dairy and non-dairy products are now sold across the United States, Mexico, Ireland and the United Kingdom. Learn how Lifeway is good for more than just you at www.lifewaykefir.comForward-Looking Statements All statements in this release (and oral statements made regarding the subjects of this release) contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, market position, business strategy and objectives. These statements use words, and variations of words, such as “expect,” “vision,” “will,” “predict,” “grow,” and “trend.” Other examples of forward looking statements may include, but are not limited to, (i) statements of Company plans and objectives, including the introduction of new products, or estimates or predictions of actions by customers or suppliers, (ii) statements of future economic performance, and (III) statements of assumptions underlying other statements and statements about Lifeway or its business. You are cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events and thus are inherently subject to uncertainty. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from Lifeway’s expectations and projections. These risks, uncertainties, and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; and customer acceptance of products and services. A further list and description of these risks, uncertainties, and other factors can be found in Lifeway’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, and the Company’s subsequent filings with the SEC. Copies of these filings are available online at https://www.sec.gov, http://lifewaykefir.com/investor-relations/, or on request from Lifeway. Information in this release is as of the dates and time periods indicated herein, and Lifeway does not undertake to update any of the information contained in these materials, except as required by law. Accordingly, YOU SHOULD NOT RELY ON THE ACCURACY OF ANY OF THE STATEMENTS OR OTHER INFORMATION CONTAINED IN ANY ARCHIVED PRESS RELEASE.References:[26]  G. Vinderola, G. Perdigon, J. Duarte, D. Thangavel, E. Farnworth, C. Matar, Effects of kefir fractions on innate immunity, Immunobiology. 211 (3) (2006) 149–156.[27]  H.-L. Chen, K.-F. Hung, C.-C. Yen, C.-H. Laio, J.-L. Wang, Y.-W. Lan, et al., Kefir peptides alleviate particulate matter< 4 μm (PM 4.0)-induced pulmonary inflammation by inhibiting the NF-κB pathway using luciferase transgenic mice, Sci. Rep. 9 (1) (2019) 1–13.Media Contact Cercone Brown Company +1 (908)-907-6862 lifeway@cerconebrown.com
GlobeNewswire · 11/18 17:50
Tyson leads select packaged food stocks higher
Tyson Foods ([[TSN]] +3.1%) trades higher after better-than-anticipated beef and pork demand took some of the focus of the COVID-19 cost headwinds. The report from Tyson has helped the packaged
Seekingalpha · 11/16 18:55
Lifeway Foods Q3 EPS $0.12, Sales $26.04M Up From $22.73M YoY
Lifeway Foods (NASDAQ:LWAY) reported quarterly earnings of $0.12 per share. The company reported $26.04 million in sales this quarter. This is a 14.56 percent increase over sales of $22.73 million the same period last
Benzinga · 11/16 13:17
Lifeway Foods, Inc. Reports Third Quarter 2020 Results
Third Quarter Net Sales Increase 14.6% Year-Over-Year to $26 MillionMORTON GROVE, Ill., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today reported financial results for the third quarter ended September 30, 2020.“I am pleased to report that our growth trajectory accelerated in the third quarter of 2020, with a 14.6% increase in sales compared to the third quarter of 2019,” commented Julie Smolyansky, Lifeway’s President and Chief Executive Officer. “Our core business continues to show improved velocities and our decision to focus on digital engagement to fuel online grocery purchases and grocery list initiatives has paid dividends in a retail world that has been shaped by COVID-19 buying habits. We are still investing heavily in customer acquisition strategies as we continue to market products that fit the needs of a growing number of consumers. The trends for multi-serve products with immunity supporting attributes such as probiotics, vitamin D and protein look good for the remainder of 2020 and beyond, and we intend to build on our messaging to tell the Lifeway story to those new to the category. Our results show that retailers that have partnered with Lifeway are seeing gains as we drive category growth. We look forward to expanding those partnerships with increased variety to create a win-win scenario for both consumers and retailers.”    Third Quarter Results Net sales were $26.0 million for the third quarter of 2020, an increase of 14.6% from $22.7 million in the third quarter of 2019.Gross profit as a percentage of net sales was 29.1% for the second quarter of 2020, an increase of 140 basis points from 27.7% for the second quarter of 2020. Gross profit percentage was 22.8% in prior year period. The increase versus the prior year was primarily due to the impact of favorable milk pricing, and to a lesser extent favorable freight costs. Additionally, depreciation expense increased reflecting our continued investment in manufacturing improvements.Third quarter of 2020 selling expenses decreased by 21.0% to $2.1 million compared to the third quarter of 2019 at $2.7 million. Selling expenses as a percentage of net sales were 8.1% during the third quarter compared to 11.8% for the same period in 2019.General and administrative expenses decreased $0.4 million or 4.6% to $8.7 million during the nine month period ended September 30, 2020 from $9.1 million during the same period in 2019. The decrease is primarily a result of lower compensation expense due to organizational changes made in 2019 and lower incentive compensation, partially offset by increased professional fee expense.The effective income tax rate for the nine months ended September 30, 2020 was 29.3% compared to 8.8% in the same period last year. The increase in effective tax rate is primarily the result of non-deductible compensation expense related to equity incentive awards and state tax receivables reducing the benefit associated with a pre-tax book loss in 2019, partially offset by a benefit recognized in 2020 due to the enactment of the “Coronavirus Aid, Relief, and Economic Security Act” (the CARES Act). The Company consistently reflects non-deductible officer compensation expense, non-deductible compensation expense related to equity incentive awards and separate state tax rates from year to year. Although similar items were reflected in 2019, the percentage effect is substantially different due to the difference in pre-tax income in 2020 compared to the pre-tax loss in 2019.The Company reported earnings of $0.12 per diluted share for the third quarter of 2020, an increase from earnings of $0.06 per diluted share in the second quarter of 2020, and as compared to a break-even of $0.00 per diluted share, in the third quarter of 2019.Conference Call and Webcast A pre-recorded conference call and webcast with Julie Smolyansky discussing these results with additional comments and details will be available today at approximately 8:00 a.m. ET. The webcast will be available over the Internet through the “Investor Relations” section of the Company’s website at https://lifewaykefir.com/webinars-reports/. An audio replay will be available through November 30, 2020. North American listeners may dial 844-512-2921 and international listeners may dial 412-317-6671. The passcode is 11142402.About Lifeway Foods, Inc.Lifeway Foods, Inc., which has been recognized as one of Forbes’ Best Small Companies, is America’s leading supplier of the probiotic, fermented beverage known as kefir. In addition to its line of drinkable kefir, the company also produces cupped kefir and cheese, frozen kefir, specialty cheeses, probiotic supplements and a ProBugs line for kids. Lifeway’s tart and tangy fermented dairy and non-dairy products are now sold across the United States, Mexico, Ireland and the United Kingdom. Learn how Lifeway is good for more than just you at www.lifewaykefir.com.Forward-Looking Statements This release (and oral statements made regarding the subjects of this release) contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, market position, business strategy and objectives. These statements use words, and variations of words, such as “continue,” “build,” “future,” “increase,” “drive,” “believe,” “look,” “ahead,” “confident,” “deliver,” “outlook,” “expect,” and “predict.” Other examples of forward looking statements may include, but are not limited to, (i) statements of Company plans and objectives, including the introduction of new products, or estimates or predictions of actions by customers or suppliers, (ii) statements of future economic performance, and (III) statements of assumptions underlying other statements and statements about Lifeway or its business. You are cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events and thus are inherently subject to uncertainty. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from Lifeway’s expectations and projections. These risks, uncertainties, and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; and customer acceptance of products and services. A further list and description of these risks, uncertainties, and other factors can be found in Lifeway’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, and the Company’s subsequent filings with the SEC. Copies of these filings are available online at https://www.sec.gov, http://lifewaykefir.com/investor-relations/, or on request from Lifeway. Information in this release is as of the dates and time periods indicated herein, and Lifeway does not undertake to update any of the information contained in these materials, except as required by law. Accordingly, YOU SHOULD NOT RELY ON THE ACCURACY OF ANY OF THE STATEMENTS OR OTHER INFORMATION CONTAINED IN ANY ARCHIVED PRESS RELEASE. Contact:Lifeway Foods, Inc. Phone: 847-967-1010 Email: info@lifeway.net LIFEWAY FOODS, INC. AND SUBSIDIARIES Consolidated Balance Sheets September 30, 2020 and December 31, 2019 (In thousands)  September 30, 2020 (Unaudited)  December 31, 2019  Current assets         Cash and cash equivalents $7,616  $3,836  Accounts receivable, net of allowance for doubtful accounts and discounts and allowances of $1,410 and $1,100 at September 30, 2020 and December 31, 2019, respectively  8,159   6,692  Inventories, net  6,472   6,392  Prepaid expenses and other current assets  1,339   1,598  Refundable income taxes  189   681  Total current assets  23,775   19,199            Property, plant and equipment, net  21,082   22,274  Operating lease right-of-use asset  380   738            Intangible assets         Goodwill and indefinite-lived intangibles  12,824   12,824  Other intangible assets, net  35   152  Total intangible assets  12,859   12,976            Other assets  1,800   1,800  Total assets $59,896  $56,987            Current liabilities         Accounts payable $6,036  $5,282  Accrued expenses  2,890   4,087  Accrued income taxes  176   154  Total current liabilities  9,102   9,523  Line of credit  2,763   2,745  Operating lease liabilities  198   488  Deferred income taxes, net  1,292   922  Other long-term liabilities  35   58  Total liabilities  13,390   13,736            Commitments and contingencies                   Stockholders' equity         Preferred stock, no par value; 2,500 shares authorized; no shares issued or outstanding at September 30, 2020 and December 31, 2019  –   –  Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 15,605 and 15,710 outstanding at September 30, 2020 and December 31, 2019, respectively  6,509   6,509  Paid-in capital  2,532   2,380  Treasury stock, at cost  (12,450)  (12,601) Retained earnings  49,915   46,963  Total stockholders' equity  46,506   43,251            Total liabilities and stockholders' equity $59,896  $56,987            LIFEWAY FOODS, INC. AND SUBSIDIARIES Consolidated Statements of Operations For the three and nine Months Ended September 30, 2020 and 2019 (Unaudited) (In thousands, except per share data)  Three Months Ended September 30,  Nine Months Ended September 30,    2020  2019  2020  2019                Net sales $26,039  $22,729  $76,441  $70,497                    Cost of goods sold  17,710   16,813   53,613   51,223  Depreciation expense  752   743   2,326   2,235  Total cost of goods sold  18,462   17,556   55,939   53,458                    Gross profit  7,577   5,173   20,502   17,039                    Selling expenses  2,116   2,679   7,411   8,509  General and administrative  2,805   2,710   8,681   9,100  Amortization expense  39   39   117   152  Total operating expenses  4,960   5,428   16,209   17,761                    Income (loss) from operations  2,617   (255)  4,293   (722)                   Other income (expense):                 Interest expense  (27)  (65)  (96)  (202) Gain on investments  –   –   4   –  (Loss) gain on sale of property and equipment  –   154   (28)  183  Other income, net  –   77   2   82  Total other income (expense)  (27)  166   (118)  63                    Income (loss) before provision for income taxes  2,590   (89)  4,175   (659)                   Provision (benefit) for income taxes  764   (17)  1,223   (58)                   Net income (loss) $1,826  $(72) $2,952  $(601)                   Earnings (loss) per common share:                 Basic $0.12  $(0.00) $0.19  $(0.04) Diluted $0.12  $(0.00) $0.19  $(0.04)                   Weighted average common shares:                 Basic  15,602   15,740   15,595   15,761  Diluted  15,642   15,740   15,621   15,761  LIFEWAY FOODS, INC. AND SUBSIDIARIES Consolidated Statements of Cash Flows (Unaudited) (In thousands)  Nine months ended September 30,    2020  2019  Cash flows from operating activities:         Net income (loss) $2,952  $(601) Adjustments to reconcile net income (loss) to operating cash flow:         Depreciation and amortization  2,443   2,387  Non-cash interest expense  17   17  Non-cash rent expense  (38)  –  Bad debt expense  (3)  20  Deferred revenue  (73)  (73) Stock-based compensation  274   714  Deferred income taxes  369   –  Loss (gain) on sale of property and equipment  28   (183) Reserve for inventory obsolescence  –   177  (Increase) decrease in operating assets:         Accounts receivable  (1,464)  (316) Inventories  (80)  (1,118) Refundable income taxes  492   1,921  Prepaid expenses and other current assets  248   (399) Increase (decrease) in operating liabilities:         Accounts payable  756   2,397  Accrued expenses  (595)  53  Accrued income taxes  22   (43) Net cash provided by operating activities  5,348   4,953            Cash flows from investing activities:         Purchases of property and equipment  (1,168)  (610) Proceeds from sale of property and equipment  5   513  Purchase of investments  –   (15) Net cash used in investing activities  (1,163)  (112)           Cash flows from financing activities:         Purchase of treasury stock  (405)  (538) Repayment of line of credit  –   (1,789) Net cash used in financing activities  (405)  (2,327)           Net increase in cash and cash equivalents  3,780   2,514            Cash and cash equivalents at the beginning of the period  3,836   2,998            Cash and cash equivalents at the end of the period $7,616  $5,512            Supplemental cash flow information:         Cash paid for income taxes, net of (refunds) $335  $(1,937) Cash paid for interest $82  $214  Non-cash investing activities         Right-of-use assets recognized at ASU 2016-02 transition $–  $944  Operating lease liability recognized at ASU 2016-02 transition $–  $997  Increase (decrease) in right-of-use assets and operating lease liabilities recognized after ASU 2016-02 transition $(58) $280  Non-cash financing activities         Issuance of common stock under equity incentive plans $522  $–
GlobeNewswire · 11/16 13:00
GameStop and Cars.com among consumer gainers; Electrameccanica Vehicles among losers
Gainers: Yunhong CTI (CTIB) +21%. Cars.com (CARS) +19%. Full House Resorts (FLL) +13%. Sleep Number (SNBR) +12%. GameStop (GME) +11%.Losers: Leaf Group (LEAF) -16%. iHuman (IH) -9%. Electrameccanica Vehicles (SOLO) -9%. Energy
Seekingalpha · 10/15 16:00
Roku and Peloton among consumer gainers; Nikola leads losers after founder resigns
Gainers: Roku (ROKU) +16%. Super League Gaming (SLGG) +11%. China Liberal Education Holdings (CLEU) +10%. Digital Media Solutions (DMS) +7%. Peloton Interactive (PTON) +7%.Losers: Nikola (NKLA) -20%. Travelzoo (TZOO) -18%. Qurate Retail (QRTEB) -17%. Lifeway Foods (LWAY) -16%. Francesca's Holdings
Seekingalpha · 09/21 16:00
If You Had Bought Lifeway Foods (NASDAQ:LWAY) Shares A Year Ago You'd Have Earned163% Returns
Simply Wall St. · 09/15 16:37
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LWAY. Analyze the recent business situations of Lifeway Foods through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LWAY stock price target is 11.00 with a high estimate of 11.00 and a low estimate of 11.00.
EPS
Institutional Holdings
Institutions: 41
Institutional Holdings: 1.46M
% Owned: 9.37%
Shares Outstanding: 15.60M
TypeInstitutionsShares
Increased
5
30.67K
New
8
-41.75K
Decreased
8
29.18K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Food Processing
+0.29%
Food & Tobacco
+0.02%
Key Executives
Chairman/Director
Ludmila Smolyansky
President/Chief Executive Officer/Secretary/Director
Julie Smolyansky
Chief Financial Officer/Chief Accounting Officer/Controller/Treasurer
Eric Hanson
Chief Operating Officer/Director
Edward Smolyansky
Executive Vice President/Director of Sales
Amy Feldman
Lead Director/Independent Director
Jason Scher
Director
Dorri McWhorter
Independent Director
Renzo Bernardi
Independent Director
Jody Levy
Independent Director
Pol Sikar
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 0.08
05/29/2013
05/03/2012
Dividend USD 0.07
05/25/2012
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About LWAY
Lifeway Foods, Inc. (Lifeway) is engaged in the manufacturing of probiotic, cultured, functional dairy health food products. The Company is engaged in the sale of fermented dairy products, which are produced and are sold to consumers through a network of distributors and retailers in the United States. Through its distributors, the Company also sells its products to retailers in Mexico, Costa Rica, Dubai, Hong Kong, China and the Caribbean. The Company's primary product is kefir, a dairy beverage similar to but distinct from yogurt, in various flavors and in various package configurations. In addition to the drinkable products, Lifeway manufactures Lifeway Farmer Cheese, a line of various farmer cheeses. Kefir also serves as a base for lower-calorie dressings, dips, marinades, soups or sauces and as a basic ingredient in other home-prepared foods. Recipes are made available through the Company's Website. The Company also markets and sells its ProBugs line of drinkable kefir.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Lifeway Foods, Inc. stock information, including NASDAQ:LWAY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LWAY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LWAY stock methods without spending real money on the virtual paper trading platform.